Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STROKE75+: Edoxaban Added to Antiplatelet Therapy for Secondary Stroke Prevention in Older Adults
NCT07454707Phase 3Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Nov 2026
- Primary completion
- Dec 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edoxaban in ischemic stroke, sponsored by Sunnybrook Health Sciences Centre. Started Nov 2026; status: recruiting.
02
Drugs
edoxaban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07454707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07454707.